Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Approach for Basal Insulin Titration: A Proof-of-Concept Study

NCT04864977 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT04864977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04864977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Approach for Basal Insulin Titration: A Proof-of-Concept Study
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Withdrawn
Start date
August 16, 2021
Completion date
June 6, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes, type 2 diabetes treated with insulin